#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Dan Lunz Email
CEO & Co-founder . Capsulomics
How to contact Dan Lunz
Join and see Dan's contact info for free!Current Roles
Employees:
12Revenue:
$930kAbout
Capsulomics is on a mission to detect cancer of the esophagus and its pre-cancerous condition, Barrett's esophagus early... when it can more effectively be treated, and often cured. An esophageal cancer diagnosis is something that nobody wants to hear. Today, this cancer takes 16,000 lives in the United States each year. The primary reason - the current detection method, upper endoscopy, is both invasive and expensive, so it's often not used until symptoms arise. In over 75% of cases, this is after the cancer has already spread and treatment options are limited, leading to esophageal cancer being the 3rd most lethal cancer in the United States (behind only pancreatic and lung cancer). Capsulomics early-detection system combines a simple routine test given as part of routine care with our patented DNA biomarkers that accurately test for disease. Our system is convenient, inexpensive, and accurate, so it can be given to those at risk before cancer symptoms, empowering patients to know earlier, receive necessary treatments, and live a healthier, longer life.Capsulomics Address
2401 W. Belvedere AvenueBaltimore, MD
United States